PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.2232
+0.0017 (0.77%)
At close: Aug 26, 2026, 4:00 PM EDT
0.2305
+0.0073 (3.27%)
Pre-market: Aug 27, 2026, 9:09 AM EDT
PDS Biotechnology Stock Forecast
PDSB's stock price has decreased by -82.83% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, PDS Biotechnology stock has a consensus rating of "Strong Buy" and an average price target of $5.75. The average 1-year stock price forecast is 2,476.16% higher than the current stock price, while the lowest is $4.50 (+1,916.13%) and the highest is $7.00 (+3,036.20%).
Price Target: $5.75 (+2,476.16%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PDS Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +3,036.20% | Aug 26, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $3 | Buy | Maintains | $3 | +1,244.09% | Apr 8, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $4.5 | Buy | Reiterates | $4.5 | +1,916.13% | Apr 2, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.50
from -0.74
EPS Next Year
-0.41
from -0.50
EPS and Forward PE are based on non-GAAP adjusted numbers.